Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Genenews Ltd (OTHER OTC: GNWSF)

$0.17 USD -$0.02 (-11.41%)
Last Price $0.17
Net Change $-0.0219 (-11.41%)
Bid $0
Ask Price $0
Open Price $0.17
Previous Close Price $0.1919
High Price $0.17
Low Price $0.17
Number of Trades 0
Volume 60,000
Fifty Two Week High $0.527 (2016-10-10)
Fifty Two Week Low $0.115 (2016-08-02)
Average Daily Volume 36,941
Share Outstanding 87,930 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $0
Recent Earnings $
Annual EPS $-0.02
Last Quarter EPS $
Market Capitalization $0.01B
Insider Shareholders % 0%
Annual Revenue $0B
No. Shares Outstanding 87,930
Inst. Shareholder % 0.01%
Annual Net Income $0B
TTM Net Profit Margin $100.01
1-Year Return 42.02%
3-Year Return -84.21%
5-Year Return -79.32%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD %
Dividends per Share $
Stock Split Ratio 1-6
Beta 7.6
GeneNews Ltd. is a molecular diagnostics company. It focused on the development and application of functional genomics to enable early diagnosis and personalized health management based on disease specific biomarkers. The company's patented core platform technology consists of the Sentinel Principle(R) which detects and stages virtually any disease or medical condition from a simple blood sample. It applies the Sentinel Principle in the areas of cancer, arthritis, cardiovascular diseases and neurological disorders. The company's lead product includes ColonSentry(R), a blood-based molecular test to pre-screen and assess an individual's risk of having colorectal cancer. GeneNews Ltd. is headquartered in Richmond Hill, Canada.

GNWSF News & Stock Updates